indomethacin has been researched along with Gram-Positive Bacterial Infections in 1 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Gram-Positive Bacterial Infections: Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetic parameters of vancomycin in a neonatal population have been characterized to enable development of optimum dosage guidelines for neonatal intensive-care units and to examine the relationship between these pharmacokinetic parameters and various demographic, developmental and clinical factors which might be associated with changes in the kinetic profile of vancomycin." | 1.30 | The kinetic profile of vancomycin in neonates. ( Almeida, AM; Bispo, MA; Costa, IM; Falcão, AC; Falcão, F; Palminha, JM; Reis, E; Silva, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, R | 1 |
| Reis, E | 1 |
| Bispo, MA | 1 |
| Almeida, AM | 1 |
| Costa, IM | 1 |
| Falcão, F | 1 |
| Palminha, JM | 1 |
| Falcão, AC | 1 |
1 other study available for indomethacin and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
The kinetic profile of vancomycin in neonates.
Topics: Body Weight; Critical Care; Drug Interactions; Female; Gram-Positive Bacterial Infections; Guideline | 1998 |